9.64

0.73% 0.07

Pre-market: 9.95 0.31 +3.22%

Perrigo Company Plc (PRGO)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split Dividend History

Perrigo Company Plc stock is traded at $9.64, with a volume of 3.77M. It is up +0.73% in the last 24 hours and down -34.02% over the past month. Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Previous Close:

$9.57

Open:

$9.4

24h Volume:

3.77M

Relative Volume:

1.07

Market Cap:

$1.33B

Revenue:

$4.25B

Net Income/Loss:

$-1.40B

P/E Ratio:

-0.938

EPS:

-10.2775

Net Cash Flow:

$143.60M

1W Performance:

-6.41%

1M Performance:

-34.02%

6M Performance:

-54.93%

1Y Performance:

-65.25%

1-Day Range:

$9.31

$9.81

1-Week Range:

$9.225

$10.22

52-Week Range:

$9.225

$28.43

Perrigo Company Plc Stock (PRGO) Company Profile

Name

Perrigo Company Plc

Sector

Healthcare (1113)

Industry

Drug Manufacturers - Specialty & Generic (84)

Phone

269-673-8451

Address

THE SHARP BUILDING, DUBLIN 2

Employee

8,100

Twitter

@perrigocompany

Next Earnings Date

2024-11-06

Latest SEC Filings

PRGO's Discussions on Twitter

Compare PRGO vs TAK, ZTS, HLN, TEVA, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PRGO Perrigo Company Plc	9.64	1.33B	4.25B	-1.40B	143.60M	-10.28
TAK Takeda Pharmaceutical Co Adr	18.04	56.99B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	115.93	48.94B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	9.70	43.30B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	29.14	33.94B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	531.82	23.31B	3.18B	1.33B	1.04B	27.90

Perrigo Company Plc Stock (PRGO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-06-25	Downgrade	JP Morgan	Overweight → Neutral
Jan-14-25	Downgrade	Argus	Buy → Hold
Jan-06-25	Downgrade	Piper Sandler	Overweight → Neutral
Sep-24-24	Resumed	Jefferies	Hold
Nov-17-23	Initiated	Piper Sandler	Overweight
Mar-07-23	Initiated	Canaccord Genuity	Buy
Sep-14-22	Upgrade	Argus	Hold → Buy
Sep-06-22	Upgrade	Wells Fargo	Equal Weight → Overweight
Oct-14-21	Upgrade	Raymond James	Mkt Perform → Outperform
Sep-30-21	Upgrade	Jefferies	Hold → Buy
Apr-07-21	Resumed	RBC Capital Mkts	Sector Perform
Jan-06-21	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Apr-17-20	Downgrade	Argus	Buy → Hold
Mar-24-20	Upgrade	JP Morgan	Neutral → Overweight
Mar-20-20	Upgrade	SVB Leerink	Mkt Perform → Outperform
Mar-18-20	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Oct-11-19	Upgrade	Argus	Hold → Buy
Mar-20-19	Initiated	SunTrust	Hold
Nov-13-18	Downgrade	Berenberg	Buy → Hold
Aug-10-18	Reiterated	Stifel	Hold
Jul-30-18	Downgrade	Argus	Buy → Hold
Jul-12-18	Downgrade	Goldman	Neutral → Sell
Jan-03-18	Initiated	Leerink Partners	Mkt Perform
Dec-08-17	Upgrade	Argus	Hold → Buy
Nov-10-17	Upgrade	RBC Capital Mkts	Underperform → Sector Perform
Oct-05-17	Reiterated	UBS	Buy
Sep-07-17	Initiated	Oppenheimer	Outperform
Aug-11-17	Upgrade	Goldman	Sell → Neutral
Aug-11-17	Reiterated	RBC Capital Mkts	Underperform
Jun-16-17	Initiated	Cantor Fitzgerald	Overweight
Jun-05-17	Downgrade	RBC Capital Mkts	Sector Perform → Underperform
Mar-03-17	Reiterated	B. Riley & Co.	Neutral

View All

Perrigo Company Plc Stock (PRGO) Latest News

Mar 24, 2026

What is Zacks Research's Forecast for Perrigo Q1 Earnings? - MarketBeat

Mar 24, 2026

Perrigo Company plc Enters Amended and Restated Credit Agreement and Creates New Financial Obligations – 8-K Filing March 2026 - Minichart

Mar 24, 2026

Mar 23, 2026

Perrigo Co. PLC stock outperforms competitors on strong trading day - MarketWatch

Mar 23, 2026

Perrigo Amends Credit Agreement, Extends Revolving Facility Maturity - TipRanks

Mar 23, 2026

EDGAR Filing Documents for 0001585364-26-000028 - SEC.gov

Mar 23, 2026

Perrigo (NYSE: PRGO) extends $1.0B revolver, keeps $972.4M term loan B - Stock Titan

Mar 23, 2026

Perrigo Co. PLC stock underperforms Friday when compared to competitors - MarketWatch

Mar 20, 2026

PERRIGO Co plc ($PRGO) CEO, President 2025 Pay Revealed - Quiver Quantitative

Mar 20, 2026

[ARS] PERRIGO Co plc SEC Filing - Stock Titan

Mar 20, 2026

Perrigo (NYSE: PRGO) details 2025 results, pay and ESG at 2026 AGM - Stock Titan

Mar 20, 2026

What is Zacks Research's Forecast for Perrigo Q2 Earnings? - MarketBeat

Mar 20, 2026

Mar 19, 2026

Perrigo Co. PLC stock underperforms Thursday when compared to competitors - MarketWatch

Mar 19, 2026

Mar 18, 2026

Perrigo Co. PLC stock underperforms Wednesday when compared to competitors - MarketWatch

Mar 18, 2026